Cyclosporin A hepatotoxicity in 66 renal allograft recipients
about
Hepatic manifestations of non-steroidal inflammatory bowel disease therapyAnimal research in liver transplantation with special reference to the dog.Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.Evolution of liver transplantation.Inhibition of liver, kidney, and intestine regeneration by rapamycinThe effect of FK 506 and CyA on the Lewis rat renal ischemia model.The hepatotropic influence of cyclosporine.Steps in immunosuppression for renal transplantation.Hepatobiliary diseases after kidney transplantation unrelated to classic hepatitis virus.Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era.Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation.Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.Distribution and concentration of cyclosporin in human blood.Analysis of liver function test abnormalities in kidney transplant recipients: 7 year experience.Liver transplantation: where it's been and where it's going.Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring.Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta1.Cyclosporin A: a new advance in transplantation.Pilot Algorithm Designed to Help Early Detection of HMG-CoA Reductase Inhibitor-Induced Hepatotoxicity.Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth.Gallstone formation after pancreas and/or kidney transplantation: an analysis of risk factors.The still uncertain identity of the channel-forming unit(s) of the mitochondrial permeability transition pore
P2860
Q26773684-EFF7FF20-7428-4623-BEF8-1706682C72EAQ34201191-B0F8F3A5-35E0-43F2-8B6B-E78CCEA050B7Q34240283-306B91ED-69E1-4871-94FB-8667E81F17F7Q34275840-45B113B4-4798-4686-82CC-6F576B479EAEQ34302032-738C121C-4513-4278-9D58-9B63CEB0AD76Q34414927-C4697BD4-15CE-49C8-BD5B-6DF328EA92E3Q34421473-22E45B61-8613-44BB-896A-96FCEA328E0CQ34497811-DC1479E0-D82A-485F-B9DC-1088ABD905B1Q34928794-50A7F7F1-AE9B-4EAD-843E-DD95569D4B08Q35194386-A77EE797-3B87-4A48-9580-3F251889C8E1Q36619363-2E6FE005-B2C3-47AF-98AE-555B5210EE3FQ36668891-473E50BF-CA68-44D3-917C-5F77C5BEEBFFQ37185897-BE8C9AE8-05CB-462F-909B-94FD8972E42EQ37563064-C8D5AA31-B927-4585-BE02-1F46C0C118D4Q39651653-7031EBC7-DE65-44FC-91B3-53A223BAAD1BQ39689835-77061A72-F92F-4C73-90B5-ADED9AC5F5FCQ40606170-353B0623-D188-4958-A367-D6DF581443FBQ40615260-6ADD75E9-C8FE-4A0B-9CA5-21E0CF64563FQ41528115-2FD18FF5-9171-47E5-BD73-28D32AA9C23AQ44247073-1A498F25-27C1-4250-A936-47F1B355F012Q50754801-B0357271-9AB9-4BDA-93FC-B13900A82A9EQ51463750-B9B2B2AD-DEA1-4025-AAC5-EE4A1D3CDB13Q57177821-1B6A2A89-01F3-4282-8BE8-6916C5620EA0
P2860
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
description
1981 nî lūn-bûn
@nan
1981 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@ast
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@en
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@nl
type
label
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@ast
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@en
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@nl
prefLabel
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@ast
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@en
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@nl
P2860
P1433
P1476
Cyclosporin A hepatotoxicity in 66 renal allograft recipients
@en
P2093
G B Klintmalm
S Iwatsuki
P2860
P304
P356
10.1097/00007890-198112000-00007
P577
1981-12-01T00:00:00Z